| RS1217292644 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS12172928 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS1217317914 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1217318105 |
PKHD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1217351630 |
CYP1B1
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 6, Congenital glaucoma |
| RS1217390170 |
PRRT2
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia |
| RS1217391623 |
SPG7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS1217416700 |
ZMPSTE24
|
Health Risk |
Pathogenic/Likely pathogenic |
Mandibuloacral dysplasia with type B lipodystrophy, ZMPSTE24-related disorder |
| RS1217462358 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS1217469928 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS1217477812 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS1217487621 |
ACSF3
|
Health Risk |
Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1217492313 |
MYO15A
|
Health Risk |
Pathogenic |
Hearing impairment, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1217507627 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1217511479 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS1217539900 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1217545832 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Melanoma |
| RS1217545964 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS12175488 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS1217566598 |
PCNT
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1217582584 |
PREPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Myasthenic syndrome, congenital |
| RS1217603879 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS1217606886 |
ADAMTS2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1217608616 |
CTF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS1217618479 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1217642695 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1217701354 |
GALNT3
|
Health Risk |
Likely pathogenic |
— |
| RS1217725909 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Inborn genetic diseases |
| RS1217750168 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS1217782958 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1217820916 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1217842024 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1217845018 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 18, Primary ciliary dyskinesia 18 |
| RS1217853804 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1217858818 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1217872164 |
ASH1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1217879599 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1217913746 |
NBN
|
Health Risk |
Pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS1217925678 |
PHGDH
|
Health Risk |
Likely pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS1217932471 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1217932827 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1217935335 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS1217945461 |
NGLY1
|
Health Risk |
Pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation |
| RS1217968843 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1217977493 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Neoplasm |
| RS1217980053 |
NRL
|
Health Risk |
Pathogenic |
— |
| RS1217989194 |
LAMA2
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS1218016810 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS1218054241 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1218073575 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1218081251 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1218098329 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, transient neonatal |
| RS1218098769 |
DNAAF11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 19, Primary ciliary dyskinesia 19 |
| RS1218108009 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Malignant tumor of breast |
| RS1218113889 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1218125365 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS1218129705 |
HK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1218169126 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group P, Fanconi anemia |
| RS1218193751 |
PCBD1
|
Health Risk |
Likely pathogenic |
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency, Pterin-4 alpha-carbinolamine dehydratase 1 deficiency |
| RS1218198013 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Jeune thoracic dystrophy, DYNC2H1-related disorder |
| RS1218240557 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1218246247 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS1218254964 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1218259827 |
APC
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1218260846 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS1218279399 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1218288858 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1218292786 |
CEP164
|
Health Risk |
Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS1218299104 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS1218307301 |
TNFAIP3
|
Health Risk |
Likely pathogenic |
— |
| RS1218312896 |
DSPP
|
Health Risk |
Conflicting classifications of pathogenicity |
Dentinogenesis imperfecta type 2, Inborn genetic diseases |
| RS1218322078 |
SFTPB
|
Health Risk |
Pathogenic |
— |
| RS1218404300 |
PRSS56
|
Health Risk |
Pathogenic |
Isolated microphthalmia 6, Isolated microphthalmia 6 |
| RS1218449046 |
CACNA2D1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS1218452123 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS1218453896 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1218465638 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Cardiovascular phenotype |
| RS1218470259 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS1218485537 |
TRPC6
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis, Focal segmental glomerulosclerosis |
| RS1218494857 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1218512317 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1218545995 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS1218545996 |
CHD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1218564193 |
AR
|
Health Risk |
Likely pathogenic |
Male infertility, Male infertility |
| RS1218568487 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1218568607 |
IMPDH1
|
Health Risk |
Pathogenic |
— |
| RS1218573239 |
GON7
|
Health Risk |
Pathogenic |
Galloway-Mowat syndrome 9, Galloway-Mowat syndrome |
| RS1218576358 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1218582533 |
LRP4
|
Health Risk |
Pathogenic |
Sclerosteosis 2, Cenani-Lenz syndactyly syndrome |
| RS1218605372 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1218605669 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS1218620893 |
NOBOX
|
Health Risk |
Likely pathogenic |
Premature ovarian failure 5, Premature ovarian failure 5 |
| RS1218625160 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS1218651787 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Idiopathic hypereosinophilic syndrome |
| RS1218679983 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1218684009 |
ORC4
|
Health Risk |
Pathogenic |
— |
| RS1218693745 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1218693921 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1218695159 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1218712729 |
KIF5A
|
Health Risk |
risk factor |
Amyotrophic lateral sclerosis, susceptibility to |